Live
- Governor Jishnu Dev Attends 'World Meditation Day' Celebration at Gachibowli Stadium
- CM Revanth Reddy Pays Tribute to Freedom Fighter Gaddam Venkataswamy
- Market Outlook: US bond yields, dollar index, FII data key triggers for next week
- Remembering maths genius Ramanujan
- The Third Eye: Ensuring an efficient governance
- Service activities of Ambica Sishu Kendra hailed
- Help in comprehensive development of Nellore dist
- Death toll in Punjab building collapse rises to two
- Make Christmas celebrations merrier and healthier with California almonds
- A carrom ball that bowled everyone: PM writes to Ashwin on his retirement
Laurus Labs' Q2 net profit at Rs 57 crore
Laurus Labs Ltd on Friday announced that its total revenue grew by 21 per cent to Rs 712 crore against Rs 588 crore during Q2 FY' 19.
Hyderabad: Laurus Labs Ltd on Friday announced that its total revenue grew by 21 per cent to Rs 712 crore against Rs 588 crore during Q2 FY' 19.
The city-based drug-maker said, profit after tax (PAT) for the quarter ended September 30, 2019 was up by 249 per cent to Rs 56.6 crore against Rs 16.2 crore during the corresponding period last fiscal.
Satyanarayana Chava, CEO, Laurus Labs said, "the performance during the quarter shows the ability to execute the long-term strategy of the company with enhanced revenue from formulations business contributing positively to both topline and margins."
He further said: "We have recorded robust growth across most of our divisions.
The API (active pharmaceutical ingredient) division showed a strong growth during the quarter on the back of increase in new product additions, with oncology and synthesis maintaining their growth momentum."
